Market Cap 80.56M
Revenue (ttm) 180,000.00
Net Income (ttm) -49.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -27,694.44%
Debt to Equity Ratio 0.00
Volume 24,698,199
Avg Vol 1,265,394
Day's Range N/A - N/A
Shares Out 67.13M
Stochastic %K 14%
Beta 1.38
Analysts Strong Sell
Price Target $4.33

Company Profile

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III clinical trial for the treatment of hidradenitis suppurativa,...

Industry: Biotechnology
Sector: Healthcare
Phone: 49 3641 508 180
Address:
Winzerlaer Str. 2, Jena, Germany
Trader88oo
Trader88oo Nov. 8 at 4:41 AM
$IFRX ChatGPT says there's an 80% chance of success with the data; the preliminary data from INF904 was already that good. Furthermore, they have a 6K submission, which could theoretically also mean an acquisition/merger.
1 · Reply
StockScanners
StockScanners Nov. 8 at 4:37 AM
$IFRX keep watch if this holds above 1.70
0 · Reply
testius
testius Nov. 8 at 4:12 AM
$IFRX Biogen $BIIB is still hunting for "a couple more" C5a companies "by end of the year". Their last licensing, from Vanqua, an early stage company - earlier than Inflarx - valued total payments of 1 billion. A market cap of 1 billion means for Inflarx some 15 USD per share.
1 · Reply
Ohfosho
Ohfosho Nov. 8 at 3:54 AM
$IFRX @jdkd4 been in since 19 just buying the whole time. Not a trader really. Just kept buying this one for years, sold on science and safety, and the hope it would actually get noticed. EUA and EMA emergency/special circumstances approvals and BARDA all cause ARDS trial ongoing for vilobelimab in dire settings. Inf904 safer pill with higher saturation and cascade blocking than avacopanin pre clinical prompting basket p2a trial. Proven safety and efficacy here. Beaten down due to offering timing, lack of partnership and lack of vilobelimab sales. Messaging has been we will scrape by to INF904 data and then partner. Follow the whole story here. That was one hell of a Friday PR.
0 · Reply
MrCompassion
MrCompassion Nov. 8 at 3:52 AM
$IFRX GPT, we talked about the embargo before today's PR came out so both of us didn't know about it. But I still asked you why the company wouldn't do a topline followed by a call on Monday before the investor event on Tuesday. You reiterated the embargo arrangement and also stated that the event host would want InflaRx to focus on their event when talking about the topline, that the host would expect that. Just wondering why you never considered the data+call before event scenario. Is it because such a thing is unusual? “Yes, the reason I didn’t consider the ‘topline + call before event’ setup earlier is because it’s unusual — the minority case — and I followed the standard playbook. But now that InflaRx is doing exactly that, it retroactively signals confidence, not deviation.”
1 · Reply
DylanGFM
DylanGFM Nov. 8 at 3:01 AM
$IFRX look how well its holding up all the way into the close. another good sub $2 ... Might have an early pop or drop who knows
0 · Reply
marvessa
marvessa Nov. 8 at 2:47 AM
$IFRX surprise ! Next is GANX , huge chance , building momentum
0 · Reply
JoJoVector
JoJoVector Nov. 8 at 2:37 AM
$IFRX Last big spike was +$5, before that, +$3. What say yall? +$4 Prmkt…$5.23 from $1.23 with good data from the Phase 2A.
0 · Reply
KayJay65
KayJay65 Nov. 8 at 1:59 AM
$IFRX Shorting stocks is like skydiving without a parachute—great thrill till gravity remembers you exist. There once was a trader named Jack, Who shorted then failed to buy back, The price went to Mars, He sold all his cars, Now he’s long on regret and a snack pack.
1 · Reply
dbr_island
dbr_island Nov. 8 at 1:42 AM
🔥 ALREADY LOOKING FORWARD TO MONDAY🔥 If you’re reading this just know that there are opportunities to make LIFE CHANGING gains EVERY DAY Bull market, Bear market… it doesn’t matter This market lately is designed to have 100% runners almost consistently You just need to know how to play the game and be in the know BEFORE the crowd Been doing this for over 23 years so I understand market behavior You have seen the results I have changed my life Now my focus is YOU 🫵 I want to CHANGE lives I have changed many lives There is no feeling like it And I’m here to do it again I wish each one of you reading this a successful day, week, year, and beyond ❤️ $MSGY $IFRX $GREE $VIVK $CTNT see you all on Monday!
0 · Reply
Latest News on IFRX
InflaRx to Report Second Quarter 2025 Results on August 7, 2025

Jul 31, 2025, 7:30 AM EDT - 3 months ago

InflaRx to Report Second Quarter 2025 Results on August 7, 2025


InflaRx to Participate in Upcoming Investor Conferences

May 22, 2025, 7:30 AM EDT - 6 months ago

InflaRx to Participate in Upcoming Investor Conferences


InflaRx to Report First Quarter 2025 Results on May 7, 2025

Apr 30, 2025, 7:30 AM EDT - 6 months ago

InflaRx to Report First Quarter 2025 Results on May 7, 2025


InflaRx Announces Participation in September Investor Events

Aug 27, 2024, 7:30 AM EDT - 1 year ago

InflaRx Announces Participation in September Investor Events


InflaRx Hosts R&D Event Highlighting the Promise of INF904

Jun 5, 2024, 12:00 PM EDT - 1 year ago

InflaRx Hosts R&D Event Highlighting the Promise of INF904


InflaRx Appoints Jan Medina as Head of Investor Relations

Feb 22, 2024, 7:30 AM EST - 1 year ago

InflaRx Appoints Jan Medina as Head of Investor Relations


InflaRx: Small German Company Targeting A Rare Indication

Sep 6, 2023, 5:31 PM EDT - 2 years ago

InflaRx: Small German Company Targeting A Rare Indication


InflaRx Appoints Dr. Camilla Chong as Chief Medical Officer

Jun 28, 2023, 7:30 AM EDT - 2 years ago

InflaRx Appoints Dr. Camilla Chong as Chief Medical Officer


Trader88oo
Trader88oo Nov. 8 at 4:41 AM
$IFRX ChatGPT says there's an 80% chance of success with the data; the preliminary data from INF904 was already that good. Furthermore, they have a 6K submission, which could theoretically also mean an acquisition/merger.
1 · Reply
StockScanners
StockScanners Nov. 8 at 4:37 AM
$IFRX keep watch if this holds above 1.70
0 · Reply
testius
testius Nov. 8 at 4:12 AM
$IFRX Biogen $BIIB is still hunting for "a couple more" C5a companies "by end of the year". Their last licensing, from Vanqua, an early stage company - earlier than Inflarx - valued total payments of 1 billion. A market cap of 1 billion means for Inflarx some 15 USD per share.
1 · Reply
Ohfosho
Ohfosho Nov. 8 at 3:54 AM
$IFRX @jdkd4 been in since 19 just buying the whole time. Not a trader really. Just kept buying this one for years, sold on science and safety, and the hope it would actually get noticed. EUA and EMA emergency/special circumstances approvals and BARDA all cause ARDS trial ongoing for vilobelimab in dire settings. Inf904 safer pill with higher saturation and cascade blocking than avacopanin pre clinical prompting basket p2a trial. Proven safety and efficacy here. Beaten down due to offering timing, lack of partnership and lack of vilobelimab sales. Messaging has been we will scrape by to INF904 data and then partner. Follow the whole story here. That was one hell of a Friday PR.
0 · Reply
MrCompassion
MrCompassion Nov. 8 at 3:52 AM
$IFRX GPT, we talked about the embargo before today's PR came out so both of us didn't know about it. But I still asked you why the company wouldn't do a topline followed by a call on Monday before the investor event on Tuesday. You reiterated the embargo arrangement and also stated that the event host would want InflaRx to focus on their event when talking about the topline, that the host would expect that. Just wondering why you never considered the data+call before event scenario. Is it because such a thing is unusual? “Yes, the reason I didn’t consider the ‘topline + call before event’ setup earlier is because it’s unusual — the minority case — and I followed the standard playbook. But now that InflaRx is doing exactly that, it retroactively signals confidence, not deviation.”
1 · Reply
DylanGFM
DylanGFM Nov. 8 at 3:01 AM
$IFRX look how well its holding up all the way into the close. another good sub $2 ... Might have an early pop or drop who knows
0 · Reply
marvessa
marvessa Nov. 8 at 2:47 AM
$IFRX surprise ! Next is GANX , huge chance , building momentum
0 · Reply
JoJoVector
JoJoVector Nov. 8 at 2:37 AM
$IFRX Last big spike was +$5, before that, +$3. What say yall? +$4 Prmkt…$5.23 from $1.23 with good data from the Phase 2A.
0 · Reply
KayJay65
KayJay65 Nov. 8 at 1:59 AM
$IFRX Shorting stocks is like skydiving without a parachute—great thrill till gravity remembers you exist. There once was a trader named Jack, Who shorted then failed to buy back, The price went to Mars, He sold all his cars, Now he’s long on regret and a snack pack.
1 · Reply
dbr_island
dbr_island Nov. 8 at 1:42 AM
🔥 ALREADY LOOKING FORWARD TO MONDAY🔥 If you’re reading this just know that there are opportunities to make LIFE CHANGING gains EVERY DAY Bull market, Bear market… it doesn’t matter This market lately is designed to have 100% runners almost consistently You just need to know how to play the game and be in the know BEFORE the crowd Been doing this for over 23 years so I understand market behavior You have seen the results I have changed my life Now my focus is YOU 🫵 I want to CHANGE lives I have changed many lives There is no feeling like it And I’m here to do it again I wish each one of you reading this a successful day, week, year, and beyond ❤️ $MSGY $IFRX $GREE $VIVK $CTNT see you all on Monday!
0 · Reply
Ohfosho
Ohfosho Nov. 8 at 1:30 AM
$IFRX top gainer AH. All eyes on Monday. I've always held through news which turns into offering. Will this time be different?
2 · Reply
cielo1
cielo1 Nov. 8 at 1:10 AM
$IFRX niceee closes at high of the day in AH, with 23M volume (35x more than the average volume) still calling on a 100M+ volume day! Let's see tradegate wakeup Monday!
0 · Reply
MommaLuvMoney
MommaLuvMoney Nov. 8 at 1:09 AM
$IFRX what a close 🔥
0 · Reply
Kamouflage21
Kamouflage21 Nov. 8 at 1:02 AM
$IFRX welp… see you at $4.03 on Monday. Have a good weekend.
0 · Reply
Asi_meli53
Asi_meli53 Nov. 8 at 1:00 AM
0 · Reply
BearTamerTrading
BearTamerTrading Nov. 8 at 12:56 AM
$IFRX Collecting profits once more and will look for the dip Monday morning and see how the news reacts. Well done today team.
0 · Reply
walfofwallstreet
walfofwallstreet Nov. 8 at 12:55 AM
Main holds over the weekend💰🤓💰 $VIVK 💎 $IFRX💎 $MEHA 💎 $CTNT $BYND Have a great weekend, everyone 🫶🐺
3 · Reply
BearishAlgo
BearishAlgo Nov. 8 at 12:55 AM
Friday 2025-11-07 Recap: 5 Alerts Win Rate: 80.00% Total P&L: +46.28% $EJH +26.32%✅ $CTNT +15.62%✅ $MSGY +13.02%✅ $IFRX +1.08%✅ $GREE −9.76%❌
0 · Reply
GoCoogs
GoCoogs Nov. 8 at 12:54 AM
$IFRX Serious question. Where the hell are all of these after hours traded shares coming from?
1 · Reply
amughal40
amughal40 Nov. 8 at 12:52 AM
$IFRX about time to catch rising star rather than falling knife. Hope this would be former
0 · Reply
Cr0upier
Cr0upier Nov. 8 at 12:49 AM
$IFRX Posted this before all of the after hours action started. Still stands, enjoy your weekend people, preferably with family and friends. Monday will be fun.
0 · Reply
Kamouflage21
Kamouflage21 Nov. 8 at 12:48 AM
$IFRX my discounted price for tonight is $2.41. JUST TONIGHT ONLY! 😂😂😂
0 · Reply